Help us improve surveillance in kidney cancer by taking the KCCure kidney cancer survey
KCCure talks with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC about the TIVO-3 trial and what it means for kidney cancer patients.
Why do phlebotomists take all that blood after an infusion?
I have a confession to make. I have a slight obsession with shoes...and kidney cancer clinical trials. They're not just for special occasions.
A search of National Cancer Institute website shows no new kidney cancer trials anywhere in the United States, same as last week. It's time to fund new research.
Even with tough cancers like kidney cancer, we can see miracles. In genetics research, we are seeing the miracle of the blueprint of cancer slowly unfolding.